Heavy menstrual bleeding (HMB)

Heavy menstrual bleeding (HMB) is a significant health problem in premenopausal women; it can reduce their quality ​of life and cause anaemia. One third of all women report heavy menstrual bleeding at some point in their lives, and in ​Western countries about 5 % of reproductive-aged women seek treatment for it annually. In over 50% of affected ​women no cause is found and the diagnosis of Dysfunctional Uterine Bleeding (DUB) is made.

Such statements and a lot of similar assertions are frequently reported in the literature available. They reveal how ​often you must be faced with patients complaining of bleeding disorders.

The classic definition of heavy menstrual bleeding, also called menorrhagia, is blood loss exceeding 80 ml per ​menstrual cycle, but this criteria is primarily used in research settings. In your practice, when a patient reports her ​periods to be so heavy or so long that it is interfering with her plans and activities, commonly causing stress and ​embarrassing incidents, she needs to be offered a solution.

You are of course aware that HMB is a common problem for women, which can seriously affect their quality of life. ​Being directly in contact with patients enduring bleeding disorders you know how to establish a diagnosis for each of ​your patients affected, then provide your patients with recommendations based on their medical conditions as well as ​personal expectations. You will lead your patient to the appropriate treatment and, in most cases, you will perform it. ​With Cavaterm™ Veldana Medical SA offers you a safe and easy to use solution for your patients suffering from ​dysfunctional uterine bleeding.

Cavaterm™

This second generation endometrial ablation technique consists of an adjustable, flexible silicone balloon catheter and a ​Cavabox.

The treatment combines heat and pressure during 10 minutes to irreversibly coagulate the endometrium and underlying ​myometrium to a depth of 5-8 mm.

Specific features are built in the system to ensure safety, efficacy and comfort.

The Cavaterm™ system has been successfully used since 1993. It is proven to be safe, efficient and easy to use. Over ​the past years further product developments based on users feedback were implemented for an optimal evolution of the ​system.

Many thousands of patients have been treated successfully with the Cavaterm™ system. Clinical studies report average ​success and satisfaction rates exceeding 90%, which remain stable throughout the years.

Benefits for Healthcare Professionals

Choosing the Cavaterm™ solution involves relevant advantages.

  • You will benefit from a system equipped with unique features for optimized safety for your patient.

  • The treatment safety and efficiency is well established with more than 15 years experience and thousands of patients ​successfully treated.

  • Cavaterm™ is a “see one do one” procedure; you will learn the technique quickly and easily.

  • Cavaterm™ is indicated for most uterine cavity sizes and shapes.

  • Proven features from the latest technologies will offer you and your patient the best chances for successful treatment ​outcome.

  • You will be using a Swiss quality product.

  • You will save time: the treatment cycle lasts 10 minutes and the whole procedure lasts less than half an hour.

  • The treatment can be performed under local, spinal or light general anesthesia.

  • The treatment can be performed as an outpatient procedure.

  • The Cavaterm™ treatment can be performed at any time during your patient’s menstrual cycle, and therefore ​scheduling conflicts are avoided

Benefits for Patients

Choosing the Cavaterm™ solution involves relevant advantages.

  • Your patient will be offered a minimal invasive option; she will be thankful for the improved quality of life.

  • Your patient will be given a permanent treatment.

  • Your patient‘s hormonal balance will be preserved.

  • Cavaterm™ will cause absolutely no feeling of mutilation / loss of feminity.

  • Cavaterm™ does not cause post-operative hemorrhages.

  • Post-operative infections are unlikely to happen.

  • Your patient will be able to go back home a few hours after the treatment.

  • Your patient will be back to her daily activities shortly.

  • More than 90% of all patients are satisfied with the treatment .

Interested? Let's talk